First, the increased apelin levels were reversed when blood glucose control was improved and glucotoxicity was relieved in patients with T2DM.[32,33] Second, apelin expression decreased further with antioxidant treatment by lipoic acid and methylcobalamin which led to a reduction in the oxidative stress, and hence, decreasing the damage to the tissue cells. Here, APLN is linked to type 2 diabetes mellitus.